Citation tools
"Pharmacological Characterization of FE 202158, a Novel, Potent, Selective, and Short-Acting Peptidic Vasopressin V1a Receptor Full Agonist for the Treatment of Vasodilatory Hypotension." Journal of Pharmacology and Experimental Therapeutics
337.3
(2011):
786-796.
Web. 18 April. 2024.